Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid
Quantification of Symptom Relief Following Percutaneous Ablation of the Thyroid
1 other identifier
observational
300
1 country
1
Brief Summary
The purpose of this study is to measure the impact of thyroid radiofrequency ablation procedure on patients with thyroid-related symptoms using a modified pre-existing scoring system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2022
CompletedFirst Posted
Study publicly available on registry
August 15, 2022
CompletedStudy Start
First participant enrolled
August 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2028
September 15, 2025
September 1, 2025
3.9 years
August 12, 2022
September 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in symptoms before and after ablation
Measured using a modified 6-item SYS questionnaire that objectively measures patient symptoms on a scale of 0=none, 1=moderate, 2=severe
Baseline and 1-, 3-, 6-, 12-, 18-, and 24-months following treatment
Eligibility Criteria
Adult patients undergoing ablation for symptomatic thyroid nodule(s)
You may qualify if:
- \- Undergoing Radiofrequency Ablation (RFA) for symptomatic thyroid nodule(s).
You may not qualify if:
- \- Decline to participate in research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Atwell, MD
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 12, 2022
First Posted
August 15, 2022
Study Start
August 22, 2022
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2028
Last Updated
September 15, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share